Literature DB >> 12787862

Bromocriptine augmentation therapy in a patient with Cotard's syndrome.

Shuko Kondo1, Hiroshi Hayashi, Takuya Eguchi, Takanobu Oyama, Tadashi Wada, Koichi Otani.   

Abstract

A 72-year-old female with bipolar I disorder developed Cotard's syndrome, i.e., various delusions of negation accompanied by severe depressive symptoms. She responded neither to the combination of antipsychotic drug and antidepressant nor to the lithium augmentation therapy. However, the delusions and depressive symptoms improved dramatically after the addition of bromocriptine 2.5-5 mg/day to the combination of clomipramine and lithium. This report suggests that bromocriptine augmentation therapy might be effective at least for some patients with Cotard's syndrome in mood disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787862     DOI: 10.1016/S0278-5846(03)00083-6

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  1 in total

Review 1.  Cotard's syndrome: a review.

Authors:  Hans Debruyne; Michael Portzky; Frédérique Van den Eynde; Kurt Audenaert
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.